
The study investigated lipopolysaccharide-binding protein (LBP) expression in oral and maxillofacial tumors (OMTs) and its association with clinical factors. Immunohistochemical double staining and enzyme-linked immunosorbent assay (ELISA) examined LBP expression in OMTs. The study found that LBP expression was significantly elevated in OMTs and was associated with clinical stage, T classification, and lymph node metastasis. The study suggests that LBP may contribute to the development of OMTs and could be used as a biomarker for screening and predicting metastasis in patients with OMTs.
Like
Save
Share